The PALACE Trial: Direct Oral PCN Challenge in Patients with Low-Risk PCN Allergy?
RebelEM
AUGUST 3, 2023
Patients with a history of anaphylaxis with any drug were excluded from this trial Open-label study (i.e. randomization) as per protocol (i.e. eligibility to screened ratio) Feasibility of recruitment defined as proportion of patients consenting to participate in the study protocol from eligible patients (i.e.
Let's personalize your content